Clinical Trial Update: Diaphragmatic Function as a Biomarker

View source ↗

Summary

This RWTH Aachen University trial evaluates diaphragmatic function as a biomarker in patients with asthma, COPD, pulmonary fibrosis, and pulmonary hypertension;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease
• Pulmonary Fibrosis
• Pulmonary Hypertension

Snippet

Sponsor: RWTH Aachen University | Conditions: Dyspnea; Asthmatic, COPD | Status: RECRUITING